Management and Extent of Resection for Intrahepatic Cholangiocarcinoma

Surgical Oncology Clinics of North America

Volumn 18, Issue 2, 2009, Pages 289-305

  Carpizo, Darren R ^a   D'Angelica, Michael ^b,c  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Biliary cancer; Intrahepatic cholangiocarcinoma; Liver cancer; Resection

Indexed keywords

TUMOR MARKER;

ADJUVANT THERAPY; BILE DUCT CARCINOMA; BILIARY TRACT SURGERY; CANCER CENTER; CANCER INCIDENCE; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DATA ANALYSIS; HUMAN; LAPAROSCOPY; LIVER RESECTION; LIVER TRANSPLANTATION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; METASTASIS; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REVIEW; SAFETY; STANDARDIZATION; UNITED STATES;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; HUMANS;

EID: 62549158681     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2008.12.010     Document Type: Review

References (54)

1. Malhi H., and Gores G.J. Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol 45 6 (2006) 856-867
2. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33 6 (2001) 1353-1357
3. Taylor-Robinson S.D., Foster G.R., Arora S., et al. Increase in primary liver cancer in the UK, 1979-94. Lancet 350 9085 (1997) 1142-1143
4. Kato I., Kuroishi T., and Tominaga S. Descriptive epidemiology of subsites of cancers of the liver, biliary tract and pancreas in Japan. Jpn J Clin Oncol 20 3 (1990) 232-237
5. Shin H.R., Lee C.U., Park H.J., et al. Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea. Int J Epidemiol 25 5 (1996) 933-940
6. Su W.C., Chan K.K., Lin X.Z., et al. A clinical study of 130 patients with biliary tract cancers and periampullary tumors. Oncology 53 6 (1996) 488-493
7. Tan J.C., Coburn N.G., Baxter N.N., et al. Surgical management of intrahepatic cholangiocarcinoma: a population-based study. Ann Surg Oncol 15 2 (2008) 600-608
8. Miller G., Schwartz L.H., and D'Angelica M. The use of imaging in the diagnosis and staging of hepatobiliary malignancies. Surg Oncol Clin N Am 16 2 (2007) 343-368
9. Manfredi R., Barbaro B., Masselli G., et al. Magnetic resonance imaging of cholangiocarcinoma. Semin Liver Dis 24 2 (2004) 155-164
10. Maetani Y., Itoh K., Watanabe C., et al. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roentgenol 176 6 (2001) 1499-1507
11. Nichols J.C., Gores G.J., LaRusso N.F., et al. Diagnostic role of serum CA19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc 68 9 (1993) 874-879
12. Kim Y.J., Yun M., Lee W.J., et al. Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging 30 11 (2003) 1467-1472
13. Petrowsky H., Wildbrett P., Husarik D.B., et al. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol 45 1 (2006) 43-50
14. Goere D., Wagholikar G.D., Pessaux P., et al. Utility of staging laparoscopy in subsets of biliary cancers: laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma. Surg Endosc 20 5 (2006) 721-725
15. Weber S.M., Jarnagin W.R., Klimstra D., et al. Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg 193 4 (2001) 384-391
16. Lang H., Sotiropoulos G.C., Fruhauf N.R., et al. Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period. Ann Surg 241 1 (2005) 134-143
17. Endo I., Gonen M., Yopp A.C., et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 248 1 (2008) 84-96
18. DeOliveira M.L., Cunningham S.C., Cameron J.L., et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245 5 (2007) 755-762
19. Nakagohri T., Asano T., Kinoshita H., et al. Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma. World J Surg 27 3 (2003) 289-293
20. Shimada M., Yamashita Y., Aishima S., et al. Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg 88 11 (2001) 1463-1466
21. Grobmyer S.R., Wang L., Gonen M., et al. Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Ann Surg 244 2 (2006) 260-264
22. Meyer C.G., Penn I., and James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 69 8 (2000) 1633-1637
23. Shimoda M., Farmer D.G., Colquhoun S.D., et al. Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transpl 7 12 (2001) 1023-1033
24. Goss J.A., Shackleton C.R., Farmer D.G., et al. Orthotopic liver transplantation for primary sclerosing cholangitis: a 12-year single center experience. Ann Surg 225 5 (1997) 472-481 [discussion: 81-3]
25. Broome U., Olsson R., Loof L., et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 38 4 (1996) 610-615
26. Ghali P., Marotta P.J., Yoshida E.M., et al. Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience. Liver Transpl 11 11 (2005) 1412-1416
27. Rea D.J., Heimbach J.K., Rosen C.B., et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 242 3 (2005) 451-458 [discussion: 8-61]
28. Nathan H., Pawlik T.M., Wolfgang C.L., et al. Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis. J Gastrointest Surg 11 11 (2007) 1488-1496 [discussion: 96-7]
29. Nakagohri T., Kinoshita T., Konishi M., et al. Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma. World J Surg 32 12 (2008) 2675-2680
30. Uenishi T., Kubo S., Yamazaki O., et al. Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases. J Hepatobiliary Pancreat Surg 15 4 (2008) 417-422
31. Asakura H., Ohtsuka M., Ito H., et al. Long-term survival after extended surgical resection of intrahepatic cholangiocarcinoma with extensive lymph node metastasis. Hepatogastroenterology 52 63 (2005) 722-724
32. Murakami Y., Yokoyama T., Takesue Y., et al. Long-term survival of peripheral intrahepatic cholangiocarcinoma with metastasis to the para-aortic lymph nodes. Surgery 127 1 (2000) 105-106
33. Yamamoto M., Takasaki K., Imaizumi T., et al. A long-term survivor of intrahepatic cholangiocarcinoma with lymph node metastasis: a case report. Jpn J Clin Oncol 32 6 (2002) 206-209
34. Nakagawa T., Kamiyama T., Kurauchi N., et al. Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg 29 6 (2005) 728-733
35. Suzuki S., Sakaguchi T., Yokoi Y., et al. Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma. World J Surg 26 6 (2002) 687-693
36. Paik K.Y., Jung J.C., Heo J.S., et al. What prognostic factors are important for resected intrahepatic cholangiocarcinoma?. J Gastroenterol Hepatol 23 5 (2008) 766-770
37. Tamandl D., Herberger B., Gruenberger B., et al. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma. Ann Surg Oncol 15 10 (2008) 2787-2794
38. Bodingbauer M., Tamandl D., Schmid K., et al. Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases. Br J Surg 94 9 (2007) 1133-1138
39. Shinohara E.T., Mitra N., Guo M., et al. Radiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 72 5 (2008) 1495-1501
40. Chou F.F., Sheen-Chen S.M., Chen Y.S., et al. Surgical treatment of cholangiocarcinoma. Hepatogastroenterology 44 15 (1997) 760-765
41. Thongprasert S., Napapan S., Charoentum C., et al. Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma. Ann Oncol 16 2 (2005) 279-281
42. Atiq O.T., Kemeny N., Niedzwiecki D., et al. Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump. Cancer 69 4 (1992) 920-924
43. Cantore M., Rabbi C., Guadagni S., et al. Intra-arterial hepatic chemotherapy combined with continuous infusion of 5-fluorouracil in patients with metastatic cholangiocarcinoma. Ann Oncol 13 10 (2002) 1687-1688
44. Tanaka N., Yamakado K., Nakatsuka A., et al. Arterial chemoinfusion therapy through an implanted port system for patients with unresectable intrahepatic cholangiocarcinoma: initial experience. Eur J Radiol 41 1 (2002) 42-48
45. Shitara K., Ikami I., Munakata M., et al. Hepatic arterial infusion of mitomycin C with degradable starch microspheres for unresectable intrahepatic cholangiocarcinoma. Clin Oncol (R Coll Radiol) 20 3 (2008) 241-246
46. Llovet J.M., Real M.I., Montana X., et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359 9319 (2002) 1734-1739
47. Lo C.M., Ngan H., Tso W.K., et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35 5 (2002) 1164-1171
48. Gusani N.J., Balaa F.K., Steel J.L., et al. Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience. J Gastrointest Surg 12 1 (2008) 129-137
49. Zeng Z.C., Tang Z.Y., Fan J., et al. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients. Cancer J 12 2 (2006) 113-122
50. Harrison L.E., Fong Y., Klimstra D.S., et al. Surgical treatment of 32 patients with peripheral intrahepatic cholangiocarcinoma. Br J Surg 85 8 (1998) 1068-1070
51. Weimann A., Varnholt H., Schlitt H.J., et al. Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma. Br J Surg 87 9 (2000) 1182-1187
52. Inoue K., Makuuchi M., Takayama T., et al. Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery 127 5 (2000) 498-505
53. Jan Y.Y., Yeh C.N., Yeh T.S., et al. Prognostic analysis of surgical treatment of peripheral cholangiocarcinoma: two decades of experience at Chang Gung Memorial Hospital. World J Gastroenterol 11 12 (2005) 1779-1784
54. Konstadoulakis M.M., Roayaie S., Gomatos I.P., et al. Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome. Surgery 143 3 (2008) 366-374